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A T-cell receptor escape channel allows broad
T-cell response to CD1b and membrane
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CD1 proteins are expressed on dendritic cells, where they display lipid antigens to T-cell
receptors (TCRs). Here we describe T-cell autoreactivity towards ubiquitous human mem-
brane phospholipids presented by CD1b. These T-cells discriminate between two major types
of lipids, sphingolipids and phospholipids, but were broadly cross-reactive towards diverse
phospholipids including phosphatidylcholine, phosphatidylinositol and phosphatidylethano-
lamine. The crystal structure of a representative TCR bound to CD1b-phosphatidylcholine
provides a molecular mechanism for this promiscuous recognition. We observe a lateral
escape channel in the TCR, which shunted phospholipid head groups sideways along the
CD1b-TCR interface, without contacting the TCR. Instead the TCR recognition site involved
the neck region phosphate that is common to all major self-phospholipids but absent in
sphingolipids. Whereas prior studies have focused on foreign lipids or rare self-lipids, we
deﬁne a new molecular mechanism of promiscuous recognition of common self-
phospholipids including those that are known targets in human autoimmune disease.
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Human αβ T-cells recognize antigen complexes formedfrom MHC proteins bound to diverse peptides, CD1proteins bound to diverse lipids, and MR1 presenting
small molecules1. When an αβ T-cell receptor (TCR) recognizes a
self-peptide presented by an MHC protein, the sequence and
structure of the peptide bound controls whether the T-cells
respond2,3. T-cells with high afﬁnity for MHC–self-peptide are
rarely isolated in the periphery because the negative selection
mechanism in the thymus prevents most MHC-restricted auto-
reactive T-cells from entering the circulation. Nevertheless, T-cell
autoreactivity towards self-peptide–MHC complexes occurs,
which can manifest as autoimmune disease4. With increasing
evidence that CD1 proteins present highly diverse self and foreign
lipids to αβ T-cells3, the interrelated questions of negative selec-
tion, T-cell ﬁne speciﬁcity for lipids and ratios of self and foreign
reactive T-cells in the periphery are likewise coming to the fore
for lipids.
In this study we measured T-cell responses to lipid antigens
using CD1b tetramers, which bind to antigen-speciﬁc TCRs5.
Although the four types of human CD1 antigen-presenting
molecules (CD1a, CD1b, CD1c, CD1d) are related in structure3,
CD1b has distinct cellular and immunological functions. As
compared to other human CD1 proteins, CD1b shows particu-
larly strong recycling through the most acidic endosomes6,7, use
of a particularly capacious cleft to capture large lipids8, and it is
uniquely expressed on a subset of activated macrophages in the
periphery9. CD1b was the ﬁrst of the human CD1 proteins dis-
covered to present exogenous antigens10. There is extensive evi-
dence for its presentation of mycobacterial lipids to T-cells,
including mycolic acids11, lipoarabinomannan12, glucose mono-
mycolate13, phosphatidylinositol dimannoside (PIM2)14, glycerol
monomycolate15 and sulfoglycolipids16,17. More recent results
show that CD1 protein expression18 or CD1-restricted T-cells,
can respond to lipids from other human pathogens, including
Borrelia burgdorferi19 and Gram negative bacteria20.
To investigate potentially new targets of CD1b-mediated T-cell
response, we undertook an effort to detect human T-cells
responding to mycobacterial diacyltrehalose, Borrelia burgdor-
feri glycolipid 2 and bacterial lipid extracts. The goal of the study
was to select for foreign antigen-speciﬁc T-cells, and in so doing,
identify new bacterial antigens. The approach was based on the
premise that mechanisms of negative selection likely bias the
peripheral T-cell repertoire toward TCRs with speciﬁcity for
foreign lipids. We selected for foreign lipid reactive T-cells by
using CD1b tetramers treated with pure bacterial ligands or
complex lipid extracts from bacterial pathogens. Unexpectedly,
we derived a series of CD1b-autoreactive T-cells lines with broad
responses to common self-phospholipids that are widely expres-
sed in human cellular membranes. After identifying a distinct
pattern whereby T-cells respond broadly to phospholipids in
preference to sphingolipids, we solve the basis of this response via
a ternary crystal structure of a CD1b–phosphatidylcholine–TCR
complex.
Results
CD1b-autoreactive T-cell lines are frequently isolated. To iso-
late bacteria reactive T-cells, we loaded CD1b tetramers with
foreign lipid antigens or lipid extract (Table 1). After several
rounds of T-cell sorting and expansion from blood bank-derived
buffy coats (BC) or peripheral blood mononuclear cells (PBMC)
from healthy donors (HD), we obtained oligoclonal T-cell
populations that were >85% CD1b tetramer+ (Fig. 1a and Sup-
plementary Figs. 1–5). Prior approaches using activation assays
largely failed to detect CD1b-reactive cells in unfractionated
PBMCs21,22, but these tetramer-based enrichment procedures
succeeded in recovering CD1b tetramer-positive T-cells in each of
ﬁve unrelated donors with a measured precursor frequency of
about 1 in 104 T-cells, ranging between 0.018 and 0.33% (Sup-
plementary Figs. 1–5 and Table 1). These numbers are somewhat
higher than naive MHC-restricted T-cells and lower than human
NKT-cells23. The initial CD1b tetramer+ cell populations (HD1,
BC8, BC10, BC13, BC24) were named according to the donor,
and sub-lines A, B, or C were designated when the line could be
sorted into clearly distinct subpopulations (Supplementary
Figs. 1–5).
As expected, two cell lines recognized bacterial lipids:
BC24A and HD1A (Supplementary Figs. 3-4 and Table 1).
However, all other lines showed functional autoreactivity to
CD1b proteins in the absence of added foreign lipid. For
example, lines HD1B, BC24, BC10A, as well as line BC8 and
two lines derived thereof, BC8A and BC8B, all showed
interferon-γ release in response to CD1b-transfected but not
CD1a- or CD1c-transfected human (K562 or C1R) cells
(Fig. 1b). Similarly, line BC13A upregulates the activation
marker in response to CD1b-transfected C1R cells (Fig. 1c).
Further, CD1b-dependent autoreactive T-cell responses could
be seen against monocyte-derived dendritic cells, which
represent physiological APCs (Supplementary Fig. 6). Thus,
despite using methods to select foreign lipid reactive T-cells, all
new lines showed substantial autoreactivity to CD1b.
Although somewhat counterintuitive, the recovery of CD1b-
autoreactive T-cells has been observed previously20 and could be
explained by extremely cross-reactive TCRs that do not
discriminate lipid structure, retention of self-lipids from the
expression system used to make CD1b tetramers, or antigenic
lipids expressed both by mammalian cells and bacteria. This
functional autoreactivity observed in activation assays was
conﬁrmed using untreated CD1b tetramers that carried endo-
genous self-lipids from the human expression system (CD1b-
endo) and CD1a-endo as a negative control (Fig. 1d). For ﬁve
CD1b-autoreactive sub-lines (HD1B, BC10A, BC13A, BC8B,
BC8A), the pattern of CD1b-speciﬁc tetramer staining matched
the observed CD1b-speciﬁc functional response. For donor BC24,
functional reactivity to CD1b (Fig. 1b) was likely explained by the
response of the sub-line BC24B rather than BC24C (Fig. 1d).
Overall, these results conﬁrmed CD1b autoreactivity using a
separate method that relies on TCR binding to CD1b-endo
complexes.
Table 1 T-cell lines and subpopulations
Human
subject
Selecting CD1b
tetramer
Name of T-cell
subpopulation
CD1b tetramer
staining
BC10 BBGL1 BC10A PL brighter than
SL
BC8 Brucella lipid
extract
BC8A LPA
BC8B PL but not SL
BC24 BBGL2 BC24A BBGL2
BC24B PL but not SL
BC24C PG
HD1 Diacyltrehalose HD1A Diacyltrehalose
HD1B PL but not SL
BC13 Salmonella lipid
extract
BC13A PL and SL
Summary of the T-cell lines used, including the human subject number from which the original
blood PBMC were derived, the tetramer that was used to isolate the T-cells, the antigen, the
names of the subpopulations, and their reactivity pattern. Subject numbers preceded by BC of
HD refer to blood bank-derived buffy coats or healthy donors, respectively.
PL phospholipids, SL sphingolipids, LPA lysophosphatidic acid, PG phosphatidylglycerol
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Self-lipids in CD1b complexes. Because few chemically identiﬁed
self-antigens are known for the human CD1b system, we used
these CD1b-endo complexes and the panel of CD1b-autoreactive
lines as a route to discover lipid autoantigens. Using a recently
reported mass spectrometry approach24, we identiﬁed several
lipids present in the CD1b-endo monomers used to make CD1b
tetramers. After monomers were treated with chloroform,
methanol and water, we captured lipids in the organic phase and
precipitated proteins into the aqueous phase. Lipid eluents were
subjected to negative mode nanoelectrospray ionization
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Fig. 1 CD1b tetramer selection generates autoreactive T-cell lines. a Peripheral blood mononuclear cells from blood bank-derived buffy coat 8 (BC8) were
sorted based on expression of CD3 and binding to CD1b tetramers treated with Brucella lipid extract, followed by expansion in vitro. Numbers in the
outlined red areas indicate percent cells in gate. The generation of additional T-cell lines is shown in Supplementary Figures 1–5. b IFN-γ ELISPOT assay of
T-cell lines and subpopulations stimulated with K562 or C1R cells transfected to express CD1a, CD1b, or CD1c in the absence of exogenously added
antigen. Error bars represent standard error of the mean (SEM) of triplicate wells. c Jurkat cells transduced to express the BC13A TCR were stimulated with
C1R cells transfected to express CD1a, CD1b, CD1c in the absence of exogenously added antigen. After 24 h, CD69 expression was determined by ﬂow
cytometry. d Polyclonal T-cell populations from the indicated donor were stained with CD1a-endo or CD1b-endo tetramers. T-cell line derivation (a) and
screening (b, d) was performed once on each of ﬁve donors. The experiments in c were performed twice with comparable results. APC antigen-presenting
cell
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(nanoESI) ion trapping MS, identifying ions corresponding to
deprotonated ions of phosphatidic acid (PA, m/z 673.5), phos-
phatidylethanolamine (PE, m/z 742.5), phosphatidylserine (PS,
m/z 760.5), and phosphaditylinositol (PI, m/z 885.7, 887.7, 909.8).
Further we detected chloride adducts of phosphatidylcholine (PC,
m/z 794.5, 808.5, 820.5, 822.5, 842.5 844.5) and sphingomyelin
(SM, m/z 737.5 765.5, 849.6). For some ions, these tentative
identiﬁcations based on mass alone could not be formalized due
to limited MS intensity or mass accuracy (Fig. 2a). However, for
all six lipid classes, CID mass spectrometry identiﬁed diagnostic
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ions leading to their conﬁrmed structural identiﬁcation (Supple-
mentary Fig. 7). For example, cleavage of PA25 m/z 673.5 gen-
erated fragments identiﬁable as fatty acids (m/z 255, 281), and
monoacylphosphoglycerols (m/z 391, 409, 417) (Supplementary
Fig. 7a). Considering the combined length of acylglycerol or
sphingosine units, the lipid anchors of ligands ranged from C30-
C42, with strongest signals seen for C38 and C40 lipids (Fig. 2a).
Similar results were obtained using HPLC–TOF-MS methods
(Supplementary Fig. 8).
Discovery of self-lipid antigens. In addition to lipids directly
identiﬁed in CD1b-endo complexes, we designed a larger panel of
lipids for screening in CD1b tetramer assays. These additional
lipids included lysophosphatidic acid (LPA), ganglioside M1
(GM1) and GM2 and synthetic phosphatidylinositol dimannoside
(PIM2) (Fig. 2b, c). These lipids were chosen because they are
naturally occurring, available in pure forms, and were known as
CD1 ligands in other contexts14,26,27. Recent studies on human
CD1a28,29 and CD1c30 have shown how lipids are more likely to
act as autoantigens if they have small head groups or fewer lipid
tails20,24,31,32. Smaller CD1 ligands can remain sequestered within
CD1 clefts, where head groups do not interfere with CD1-TCR
contacts. Two decades after the discovery of neural tissue-derived
glycosphingolipid presentation by CD1b33, ubiquitous antigen-
presenting cell-intrinsic CD1b-presented autoantigens have only
been recently discovered20,31 and general size constraints are
unknown. Accordingly, lipids in this panel spanned a large range
of head group size, from PA, which has no head group, to lipids
with small head groups (PS, PE, PC, SM) up to glycolipids with
one polyalcohol (inositol), or three (PIM2), four (GM2) or ﬁve
(GM1) carbohydrates. Also, this panel sampled the two main
types of lipids in mammalian membranes: glycerophospholipids
and sphingolipids. Glycerophospholipids differ from sphingoli-
pids in their ‘neck region,’ where glycerophospholipids contain an
anionic phosphate ester, and sphingolipids have an amide linkage
(Fig. 2b, c). Thus, in addition to acting as probes to deﬁne new
antigenic molecules, this panel tested lipid tails, neck regions and
head groups as determinants of CD1b-TCR contact.
We treated CD1b-endo tetramers with vehicle alone and
separately with each of the 11 lipids. These antigen-loaded CD1b
tetramers were screened for staining of 7 CD1b-autoreactive T-
cell populations. Tetramers avoid certain false positive results
seen in activation assays because tetramers rely on direct physical
interactions of TCRs with antigen complexes, but tetramers also
give false positive or negative results in some circumstances.
Therefore, it is notable that for every lipid tested, alternatively
loaded tetramers generated differential upregulating or down-
regulated binding, based on the T-cell line used (Fig. 2d–f).
Visualization of the data as a matrix of 77 staining conditions
makes clear that the seven lines provided positive and negative
controls for one another (Fig. 2g). No lipid generally failed to
bind tetramers, generally inactivated tetramers or generally
caused tetramers to bind non-speciﬁcally to T-cells. Instead
differing patterns within the matrix were most consistent with
differential interactions with clonally distributed TCRs and the
type of lipid loaded onto CD1b. This matrix identiﬁed many
lipids that could block (non-permissive ligands) or enhance
(antigens) CD1b-endo staining of T-cells, demonstrating broad
recognition of self-lipids by human CD1b-reactive T-cells.
Three patterns of self-antigen reactivity. Further, by observing
larger patterns in which few or many lipids affected T-cell
staining, as well as the general classes of lipids that controlled
staining, we could identify three general patterns of T-cell spe-
ciﬁcity for CD1b lipid-complexes. Pattern 1 was observed for
alternatively loaded tetramer staining of BC24C and BC8A T-cell
populations. Here T-cells recognized phospholipids in preference
to sphingolipids, and they speciﬁcally stained with phospholipids
carrying small head groups, such as PG and LPA (Fig. 2d). The
staining was highly speciﬁc for the lipid loaded, as there was no
cross-reactive recognition of membrane phospholipids with larger
head groups such as PC and PI. These results conﬁrmed a known
antigen response pattern previously observed in clones PG90 and
PG1020,24 and broadened the result to additional human donors.
In addition, this matrix identiﬁed two previously unknown
lipid antigen reactivity patterns for CD1b. Two T-cell popula-
tions, BC10A and BC13A, constituted pattern 2. They recognized
CD1b tetramers treated with many phospholipids or sphingoli-
pids (Fig. 2e). Despite this extreme promiscuity for lipid
structure, both lines were still speciﬁc for the CD1b isoform in
T-cell activation (Fig. 1) and tetramer staining (Fig. 2e) assays.
Last, pattern 3 was exempliﬁed by BC24B, BC8B, and HD1B
(Fig. 2f). Here T-cells showed broadly cross-reactive recognition
of many classes of self-phospholipids, including PG, PA, PI, PC,
PS, and PE. Unlike pattern 1, binding was highly promiscuous
among phospholipid types, with T-cells cross-reacting with
phospholipids lacking a head group (PA) and those with varying
head group size and structure. Like pattern 1, these lines were not
cross-reactive to any tested sphingolipid, including gangliosides
GM1, GM2, and SM (Fig. 2f). Of note, the phospholipid PC and
the sphingolipid SM have the same phosphocholine head group
(Fig. 2b) but are differentially recognized. Thus, pattern 3 suggests
that the T-cell response might be in some way speciﬁc for the
phosphoglycerol neck region that differentiates sphingolipids
from phospholipids.
Thus, screening with major classes of cellular self-lipids was
highly informative regarding the identity of individual antigens
identiﬁed, including PS, PE, PI, and SM. Pattern 3, with apparent
‘neck region’ speciﬁcity that translated into preference for
phospholipids over sphingolipids, was particularly intriguing.
To our knowledge, this pattern lacked precedent. Yet, it could
potentially explain how T-cells respond differentially to the two
major classes of membrane lipids present in human cells. Also
from a structural perspective, pattern 3 was difﬁcult to under-
stand. The only prior structural study of an autoreactive TCR
bound to CD1b, CD1b-PG-PG90 TCR, shows that head group
protrudes ‘upward’ to contact the TCR24. If head groups usually
dominate TCR contact with phospholipids, it was unclear how
pattern 3 TCRs could somehow equally recognize large (PI, PC),
small (PS, PE, PG), or absent (PA) head groups, yet still
discriminate neck region structures, which are likely positioned
further from the TCR and nearer to CD1b. Therefore, we chose
Fig. 2 Patterns of antigen speciﬁcity among CD1b-restricted T-cell lines. a Lipids were eluted from untreated CD1b proteins and analyzed by mass
spectrometry. The identities of the indicated lipids were initially established by based on m/z value matching to masses of known compounds. All six lipid
classes were conﬁrmed by collisional mass spectrometry based on diagnostic fragmentation patterns (Supplementary Fig. 7). b–f A panel consisting of 12
allophycocyanin-labeled CD1b tetramers and one CD1a tetramer, treated with the indicated phospholipid (b) or sphingolipid (c) or mock treated (endo),
was used to stain the indicated T-cell lines. g Tetramer binding data are arranged according to mean ﬂuorescence intensity (MFI) and aligned relative to
the MFI of CD1b-endo staining. An experiment using the full panel of 13 tetramers and all T-cell lines was performed once. Replicate experiments with a
smaller subset of the tetramer panel were conducted at least once for each T-cell line and tetramer
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the BC8B TCR (Fig. 2f) as a representative pattern 3 T-cell for
detailed structural studies.
Binding of a broadly cross-reactive TCR to CD1b-
phospholipid. First, we cloned and sequenced the TCR of
BC8B. The TCR α chain complementarity determining region 3
(CDR3α) sequence CALTPSGGYQKVTF was formed by the gene
segments TRAV9-2 and TRAJ13, and a CDR3β sequence
CASSMPGLRSSYEQYF was formed by TRBV6-2 and TRBJ2-7.
TCR heterodimers were generated and puriﬁed according to
published protocols24. In surface plasmon resonance (SPR)
assays, CD1b was loaded with various lipid antigens, coupled to
the surface, and recombinant BC8B TCR was the analyte (Fig. 3).
For CD1b loaded with PC, PE, PA, PI, PG, or PS, steady-state
afﬁnities were measured in the range of 5.9–15.3 μM, which
represents a high afﬁnity interaction for any self-ligand2. Very
weak binding was detected to CD1b carrying the single chain
lipid LPA (KD > 200 μM), consistent with the absence of staining
with LPA-treated tetramers (Fig. 2f, Supplementary Fig. 2). The
BC8B TCR detectably interacted with CD1b presenting the
sphingolipid antigens, SM and sulfatide, but did so with extre-
mely low afﬁnity, 60.4 and 83.6 μM, respectively, as compared
with CD1b-phospholipids. Although there were some differences
in avidity or afﬁnity among individual phospholipids, both tet-
ramer and SPR-based assays showed a clear preference for self-
phospholipids over sphingolipids and promiscuity among phos-
pholipids, implying neck region speciﬁcity.
BC8B TCR docking onto CD1b-phospholipid. Next, we deter-
mined the crystal structure of the CD1b-PC–BC8B TCR complex
to a resolution of 2.4 Å (Supplementary Table 1, Fig. 4a). The
entire PC molecule was clearly deﬁned in the electron density
map (Supplementary Fig. 9), so that its interaction with the TCR
could be analyzed in detail. Similar to prior CD1b complexes with
self-lipids24,34,35 and the detection of CD1b ligands whose lipids
are smaller than the CD1b cleft (Fig. 2a, Supplementary Fig. 9),
the large cleft of CD1b contained a scaffold lipid in addition to
the acyl chains of PC (Supplementary Fig. 9). The TCR docked
centrally with an approximate 110° angle across the antigen-
binding cleft, where the TCR contacted the lipid and CD1b
(Fig. 4a, b). The total buried surface area (BSA) of the interaction
was 1990 Å2, with equivalent contributions by the TCR α (53%)
and β (47%) chain (Fig. 4b).
The TCR α-chain dominated contacts with PC, where the
CDR1α and CDR3α regions (20% and 30% BSA, respectively)
interact with the phosphate, sn1 acyl tail, and both the α1 and α2
helices CD1b (Supplementary Table 2, Fig. 4b, c). Speciﬁcally, the
main chain of Y36α and P37α in the CDR1α loop and P108α in
the CDR3α loop form hydrogen bonds with the phosphate. S109α
of the CDR3α loop hydrogen bonds with the hydroxyl group on
the sn1 lipid tail (Fig. 4c). The hydroxyl group of Y36α of the
CDR1α forms a hydrogen bond with S109α in the CDR3α, aiding
in stabilizing the TCR interaction with PC. Furthermore, Y36α
and K58α of the CDR1α and CDR2α loops, respectively, make
contacts proximally to the CD1b α2 hinge regions (Supplemen-
tary Table 2, Supplementary Fig. 10a). Whereas CDR3α loop
contacts the PC neck region and sn1 tail regions (Fig. 4c), Y113α
contacts R79 and E80 of the α1 helix of CD1b to further anchor
CD1b-PC docking (Supplementary Table 2, Supplementary
Fig. 10b).
In contrast, TCR β lacks interactions with PC, and instead
contacts the F′ portal of CD1b (32% BSA) (Fig. 4b,
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Fig. 3 Steady-state afﬁnity measurements of BC8B TCR against CD1b by SPR. Steady-state afﬁnity measurements by SPR of the BC8B TCR against CD1b
presenting a range of phospholipid and non-phospholipid antigens. Three (CD1b-endo, CD1b-PS, and CD1b-PC) or two independent (all other antigens)
SPR experiments were conducted. Steady-state (KD) values and error bars represent mean+ SEM in μM of duplicate measurements. Sensograms (upper)
and equilibrium curves (lower) were generated in Graphpad Prism 7.0
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Supplementary Table 2, Supplementary Fig. 10c-d). CDR3β docks
across the α1 helix, with the sulfur side chain and hydroxyl
backbone of M108β and P109β, respectively, bonding with R79
(Supplementary Fig. 10d). In fact, the CDR3β loop penetrates the
F′ portal to gain access to the CD1b cleft, where L111β contacts
the buried L154 on the α2 helix and L111β amine backbone and
E80 on the α1 helix (Supplementary Fig. 10d). TCR docking onto
CD1b is further solidiﬁed by R112.1β forming salt bridges and a
hydrogen bond with D87 and D83, respectively (Supplementary
Figs. 10d and 11). While the CDR1β and CDR2β loops have lesser
roles, hydrogen bond formation between Y31β and Y113α of the
CDR1β and CDR3α loops, respectively (Supplementary Fig. 10c),
stabilize the PC antigen-binding region architecture. Overall, the
BC8B TCR binds near the center of CD1b with both chains
providing deﬁned contacts that explain CD1b and PC speciﬁcity.
Conserved TCR docking modes on CD1b. Comparison of the
BC8B TCR with the GEM42 and PG90 TCRs, the only ternary
TCR structures currently solved with CD1b24,36, provides insight
into key commonalities that underpin antigen recognition
(Fig. 4b, Supplementary Fig. 11). All three TCRs exhibit a β chain
center of mass above the α1 helix of CD1b, with contacts
spreading across the α1 helix, and bridging towards the α2 helix
(Fig. 4b)24,36. The CDR3β region contributes to signiﬁcant con-
tacts with CD1b in each case. TCR stabilization on CD1b is
partially driven by salt bridge formation between key acidic
residues on the α1 helix of CD1b, and a non-germline encoded
arginine residue present on the N-region of each CDR3β loop.
Speciﬁcally, R112.1β of the BC8B TCR binds D87 of CD1b
(Supplementary Figs. 9d and 11), whereas salt bridges form
between R110β of the PG90 TCR and E80 and D83, respectively,
and R109β of GEM42 TCR binds E80 of CD1b (Supplementary
Fig. 11). These polar interactions contribute to anchoring the
respective TCRs to allow for optimal lipid antigen co-recognition.
These similarities are observed despite the lack of signiﬁcant
conservation of TCR gene usages24,36. Conversely, both the BC8B
and GEM42 TCRs share TRBV6-2 genes, but their respective
CD1-TCR structures reveal the CDR1β and CDR2β regions have
minimal roles in CD1b and antigen contacts (Fig. 4b,
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Supplementary Table 2). Instead, the CDR1β region has an
indirect role in stabilizing the antigen-binding architecture of the
CDR3α and CDR3β regions of the BC8B and GEM42 TCRs,
respectively (Supplementary Fig. 10c). Considering the contacts
between the TCRs and their respective lipid antigens, all three
TCR footprints span across the F′ portal, allowing contact with
elements of the glycolipid (GEM42) or phospholipid (BC8B and
PG90) that protrude through the F′ portal onto the surface of
CD1b (Figs. 4b and 5a–c).
A TCR escape channel limits antigen contact. Despite these
commonalities, the key difference in antigen recognition is that
the PG90 and GEM42 TCRs are highly speciﬁc for antigen head
groups, whereas the BC8 TCR is not. For the GEM42 and PG90
TCRs, the TCRs make a tight seal on CD1b, forming a gasket-like,
O-ring seal that fully surrounds the F′ portal and protruding
antigen (Figs. 4b and 5a, b). Surrounded on all sides, glucose or
phospholipid head groups are forced upward towards the inter-
face of the TCR α and β chains. Here the two chains act like two
arms of tweezers that extensively surround and broadly contact
head groups24,36 (Fig. 5a, b). In contrast, the contacts between the
BC8B TCR and lipid antigen are predominantly limited to the
TCR α-chain, where the CDR1α and CDR3α loops contact both
the phosphocholine neck region and the sn1 lipid tail (Fig. 4c and
5c). This alternative binding mechanism propagates a differing
docking angle and TCR-CD1b contact interface creating a
reversed C-shaped TCR contact footprint (Figs. 4b and 5d).
This forms a wide channel between the CDR1α and CDR3α
loops that allows the choline head group of PC to escape laterally
across the surface of CD1b, where it rests on the A′ roof of CD1b
(Figs. 4b and 6a). The ‘bent’ conformation of the antigen allows
the anionic phosphate unit of the neck region to cradle within a
cationic cup-like surface in the TCR (Fig. 5d), with the choline
group escaping TCR contact (Fig. 4c). Overall, the BC8B TCR
escape channel provides a straightforward explanation for both
the neck region speciﬁcity for phosphoglycerol lipids over
sphingolipids, as well as the lack of head group speciﬁcity for
phospholipid subclasses: the head groups protrude laterally
through a channel in the TCR.
Two mechanisms of cationic cup formation. The electronegative
phosphocholine head group ﬁts into an electropositive pocket of
the BC8 TCR formed by the amine backbones of the TCR α chain
(Fig. 5d). This situation is reminiscent of the “cationic cup” that
was recently described in the PG90 TCR, which mediates the
phosphate unit of PG24. In both cases, the CDR loops that form
the cationic cups sequester the anionic phospholipid antigen head
group, either partially or completely for the BC8B and PG90
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TCRs, respectively. To characterize the extent of antigen and TCR
remodeling during BC8B TCR docking, we determined the crystal
structures of the CD1b-PC complex to 1.7 Å and the unliganded
BC8B TCR to 2.0 Å (Supplementary Table 1). Next these three
structures were compared with the CD1b-PG–PG90 TCR, CD1b-
PG and PG90 TCR24, demonstrating distinct mechanisms of
cationic cup formation (Fig. 5e, f). Comparison of CD1b-PG and
CD1b-PG–PG90 TCR complexes shows that TCR binding
resulted in extensive repositioning of the lipid, with the TCR β-
chain moving 7 Å toward the PG head group and vice versa,
pulling the antigen up slightly from its fully seated position in the
cleft (Fig. 5e)24. Similarly, upon BC8B TCR docking, the PC
antigen is lifted from the CD1b antigen-binding cleft in both the
A′ and C′ pockets, allowing for signiﬁcant TCR contacts with the
sn1 acyl tail. The PC head group is lifted upwards by ~6 Å and
bent, allowing for favorable contacts as the phosphate moiety is
inserted into the BC8B TCR cationic cup (Fig. 5f).
Otherwise the formation mechanisms are highly distinct with
regard to the cooperating TCR chains and the role of CD1b-
phospholipid in driving formation. Whereas the BC8B TCR
cationic cup is formed almost exclusively via the TCR α-chain
(Fig. 5d–f), the PG90 TCR cationic cup was formed from
interchain interactions among the CDR3α and CDR3β loops
(Fig. 5a, e). For BC8B, the unliganded and CD1b-complexed
BC8B TCR structures overlaid closely, with a root mean square
deviation (R.M.S.D) of 0.65 Å. No signiﬁcant movement of the
CDR1α and CDR3α loops was observed between the BC8B TCR
structures, revealing that the antigen interaction surface that
contributes to the cationic cup is pre-formed (Fig. 5f). In the case
of the PG90 TCR, the CDR3β loop undergoes a major
conformational change upon CD1b-PG docking, demonstrating
that the PG90 cationic cup is only formed after ligation (Fig. 5e).
Thus, both autoantigen-reactive CD1b-restricted TCRs solved to
data form a cationic cup, which appears to be a phosphate-
selective feature within these TCRs. However, this structure can
be pre-formed within TCR-α or generated by inter-loop
cooperation during binding of the negatively charged antigen.
Cross-reactivity explained by head group escape channel. Both
PG90 and BC8B TCRs use cationic cups to position the phos-
phate at the base of the TCR. Whereas PG90 seals tightly over the
phospholipid antigen head group24, an escape channel forms
between the CDR1α and CDR3α loops of the BC8B TCR. A
lateral view shows that this escape channel is 10 Å at its max-
imum width between the side chains of T28α and Q114α of the
CDR1α and CDR3α loops (Fig. 6a, b). This gap is large enough to
accommodate the choline head group that deﬁnes PC (Fig. 6a, b).
Although other glycerophospholipids were not co-crystalized
with CD1b, their highly analogous structures (Fig. 2b) are con-
sistent with a general mechanism in which their shared phos-
phoglycerol groups lie in the cationic cup. The 5
glycerophospholipids cross-reactively recognized by this TCR
(PE, PG, PS, PI, PA) (Fig. 2f, g) would be expected to present
ethanolamine, glycerol, serine, inositol, or no head group,
respectively, towards the escape channel. Comparison of the
molecular radii of these phospholipid head groups versus the size
of the TCR channel predicts that all ﬁve could pass through the
lateral gap in the TCR (Fig. 6c). Conversely, PIM2, which has a
core PI structure that carries two additional mannose units, is
predicted to be sterically hindered, and this ligand blocks CD1b
tetramer binding (Fig. 2f, g). Last, this model plausibly explains
why diversely loaded CD1b-endo tetramers stain the BC8B TCR.
CD1b presents several abundant-cellular phospholipids, includ-
ing PG24, PC, PS, PE, and PI (Fig. 2a). If each of these lipids act as
antigens via trans-TCR escape as proposed here, their combined
occupancy of a population CD1b monomers increase the prob-
ability that two or more TCR binding CD1b proteins are present
within any tetramer, as multimeric interactions are generally
needed for T-cell staining.
Discussion
In follow up to early evidence for phospholipid presentation by
CD1d37,38, these results provide new evidence for human T-cell
response to CD1b and a broad range of common self-
phospholipid autoantigens from unrelated human blood
donors. From each of ﬁve donors tested, we describe a set of
CD1b-restricted T-cells present in the blood that recognize ubi-
quitous self-lipids and are functionally autoreactive to CD1b-
expressing APCs. Considering the identities of the antigenic lipids
seen by these T-cell lines, they respond to phospholipids that
form the majority of the biomass of every mammalian cell
membrane. Further, we found that individual lines showed broad,
cross-reactive recognition of many antigens24,34,35, representing a
new speciﬁcity pattern that is distinct from previous studies of
CD1b-reactive T-cell clones that speciﬁcally recognize rare self-
phospholipids associated with mitochondrial stress20,24. Whereas
human B cell and immunoglobulin responses to phospholipids
have been studied for decades as manifestations of autoimmune
disease such as systemic lupus erythematosus39,40, these data
provide broader evidence for human for T-cell response to
anionic phospholipids.
Further, the ternary TCR-PC–CD1b structure contributes a
previously unknown mode of self-antigen recognition. The
ﬁrst autoreactive TCR footprint in the CD1a system bound to the
A′-roof of CD1a itself rather than lipid antigen protruding from
the F′ portal29. The ﬁrst autoreactive TCR footprint in the CD1c
system docked centrally over the CD1c antigen portal, which can
occur only when a small ligand is present that is sequestered
within CD1c and does not interfere with the TCR approach41.
These two related mechanisms emphasize TCR binding to CD1
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Fig. 6 The lateral escape channel of the BC8B TCR. a BC8B docking onto
CD1b creates a lateral escape channel above the A′ roof, to accommodate
lipid antigen. The black arrow indicates the direction of the lateral channel
opening. b The 10 Å escape channel is ﬂanked by T28α and Q114α of the
CDR1α and CDR3α loops, respectively. Distance measurement is indicated
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in Fig. 4a. c Chemical structures of the phospholipid head groups of
phosphatidic acid (PA), phosphatidylethanolamine (PE),
phosphatidylglycerol (PG), phosphatidylserine (PS), phosphatidylinositol
(PI), and phosphatidylinositol dimannoside (PIM2) are shown in
comparison to an atomic ruler
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itself, where the carried lipid essentially does not contribute to the
TCR epitope. This shared ‘absence of interference’ mechanism
favors small lipids and can account for the promiscuous recog-
nition of structurally diverse lipids, so long as the lipids do not
protrude from the cleft to substantially cover the CD1 surface42.
Here we describe a new mechanism for CD1b, where lipid head
groups take a bent conformation, positioning the anionic phos-
phate into a cationic cup in the TCR. The more distal head group
exits laterally through a 10 Å gap, which can act as a sizing
mechanism. The TCR does not signiﬁcantly interact with the
parts of the head group that enter the escape channel, which
explains its cross-reactivity to phosphatidic acid-based antigens
with absent, small or large head groups. Larger head group, like
the trisaccharide in PIM cannot likely cannot traverse escape
channel based on its measured width. Sphingolipids, including
sphingomyelin, which otherwise mimics the head group of PC,
lack an anionic neck region for the cationic cup. This bent-neck,
head group escape mechanism of BC8B contrasts with the only
known TCR and CD1b–autoantigen interaction, where the PG90
TCR is highly speciﬁc for a phosphoglycerol head group24.
In MHC–peptide–TCR structures, key interactions occur
between the TCR, MHC and upward facing residues of the
peptide bound within the MHC. These data contribute to the
view that CD1–antigen–TCR interactions operate via the similar
mechanisms. Indeed, CD1–antigen–TCR structures typically
show that the distal, upward protruding head group of the lipid
dominates antigen speciﬁcity. One counterexample is CD1b-
presentation of GM1 by CD1b27. Here, additional sugar moieties
could be added to a pentasaccharide core epitope without abro-
gating the T-cell response, leading to the speculation that the
distal moieties might escape laterally below or within the TCR.
Here we prove that the phospholipid neck region extends upward
within the crevice between the TCR chains, makes speciﬁc
interactions with a cationic cup and the head group exits laterally
through an escape channel in the TCR. Because many types of
head groups ﬁt inside the channel and are ignored, the broad
response to membrane phospholipids is mechanistically
explained.
Early functional evidence indicates that certain aspects of the
detailed mechanism observed for BC8B may be more broadly
conserved. The TCR cationic cup mechanism of recognition of
anionic phospholipids is seen in both CD1b–autoantigen–TCR
complexes solved to date, though the cup forms by two clearly
distinct mechanisms. The cationic cup observed here is pre-
formed with the TCR α chain, whereas the PG90 cationic cup is
formed by three variable loops in TCR α and β, and becomes a
recognizable structure only after contact with CD1b-
phospholipid24. Also, we isolated additional T-cell lines that
show high speciﬁcity for small head groups (pattern 1) and lines
with general phospholipid versus sphingolipid speciﬁcity (pattern
3) as examples of human T-cells recognizing common membrane
phospholipids. CD1a, CD1b, and CD1d also bind and present
membrane phospholipids, including phosphatidylcholines that
are similar or identical to lipids studied here28,41,43. For CD1d,
there is some evidence for promiscuous responses of clones to
phospholipids37, so plausibly use mechanisms similar to those
described here.
Increasing evidence for promiscuous T-cell responses to cel-
lular CD1 proteins and self-lipid antigens is beginning to raise
questions about negative regulation of such responses. For CD1a
and CD1c autoreactive T-cells can be directly detected in
unfractionated blood22,28, and our data suggest that CD1b-
autoreactive cells can be readily detected with a simple selection
procedure. The T-cell lines that we describe here, recognizing
broadly distributed, abundant phospholipids were isolated from
healthy blood bank donors. If such CD1b-speciﬁc T-cells are
generally present in human donors, the question arises as to
whether they would cause autoreactivity or autoimmunity upon
contact with any CD1b-expressing cell. Known mechanisms for
limiting autoreactivity may be in play. T-cells may be suppressed
by other cells or are inherently unable to perform inﬂammatory
functions in vivo. They may not see the proper stimulus under
steady-state conditions because the antigen, the antigen-
presenting molecule, or costimulatory factors are in limited
supply. Even though phospholipid antigens are widely available,
CD1b expression in healthy tissues in the periphery is rare44, but
can be induced by Toll-like receptors, interleukin-1, cytokines,
and other primary inﬂammatory signals8,9,45,46. Thus, in contrast
to the ubiquitous expression of MHC class I proteins, activation
and potentially harmful consequences of the T-cells described in
this paper may be limited by tightly regulated CD1b expression in
healthy tissues, and not by antigen availability.
On the other hand, such cells have the potential to cause
autoimmunity, as was recently demonstrated in mice that
expressed human CD1b and phospholipid speciﬁc TCR. These
mice developed an autoimmune skin disease, when ApoE deletion
causes marked overexpression of phospholipids in the skin31.
This study raises the possibility that CD1b and phospholipids
might play an unrecognized role in autoimmune disease. Also,
clear evidence for immune response to phospholipids via CD1b
and CD1d invites consideration of possible B cell–T-cell inter-
actions in the anti-phospholipid antibody syndrome47,48, an
autoimmune state associated with systemic lupus erythematosus
and other autoimmune diseases.
Methods
Tetramers and analytical ﬂow cytometry. CD1 monomers were obtained from
the NIH tetramer facility. For loading of monomers, 32 μg of lipid was sonicated at
37 °C for 2 h in 90 μl of 0.5% CHAPS 50mM sodium citrate buffer pH 7.4 in 10
mm diameter glass tubes. Subsequently, 20 μg CD1b monomer was added to the
tubes and incubated overnight at 37 °C. Molecular Probes streptavidin-APC or
streptavidin-PE was used for tetramerization. Human PBMC and T-cell lines were
stained with tetramers at 2 μg ml−1 in PBS containing 1% BSA and 0.01% sodium
azide. Cells and tetramer were incubated for 10 min at room temperature, followed
by addition of 3 μl of anti-CD3 (clone SK7-Fitc from BD biosciences) per 50 μl
staining and another incubation for 10 min at room temperature and 20 min at 4 °
C. Cells were analyzed using the BD LSRFortessa ﬂow cytometer and FlowJo
software.
Lipids. Phosphatidylcholine (PC, #850475; C18:1/C16:0), sphingomyelin (SM,
#860584; C18:1/C16:0), phosphatidylinositol (PI, #840042; mixture from bovine
liver with a range of fatty acids), phosphatidylserine (PS, #840032; mixture from
porcine brain with a range of fatty acids), phosphatidic acid (PA, #840857; C18:1/
C16:0), lyso-PA (#857130; C18:1), phosphatidylethanolamine (PE, #850757 C18:1/
C16:0), phosphatidylglycerol (PG, #840503; C18:1/C18:0), and sulfatides
(#131305P; mixture from porcine brain with a range of fatty acids) were purchased
from Avanti polar lipids. Gangliosides GM1 (G7641; mixture from bovine brain
with a range of fatty acids) and GM2 (G8397; mixture from bovine brain with a
range of fatty acids) were purchased from Sigma. Phosphatidylinositol dimanno-
side (PIM) and diacyltrehalose (DAT), previously described as DAT2a49, were
provided by the Bill and Melinda Gates Foundation lipid bank. Cholesteryl 6-O-
palmitoyl-β-galactopyranoside, also known as Borrelia burgdorferi glycolipid 1
(BBGL1) and 1,2-dioleyl-α-galactosyl-glycerol, also known as Borrelia burgdorferi
glycolipid 2 (BBGL2) were synthesized as described previously50,51. Salmonella
Typhi was cultured in Luria Broth. Brucella melitensis human isolate, strain
X10017283-001 (CVI) was cultured in Tryptic Soy Broth. Lipid extracts were
prepared by extracting bacterial pellet with choroform/methanol 1:2 (V:V) for 2 h
at room temperature, followed by chloroform/methanol 2:1.
CD1b–lipid complex analysis. Human CD1b proteins made in U293 cells at the
NIH tetramer facility as described5,24 were transferred into a 15-ml glass tube and
extracted with chloroform, methanol and water according to the Bligh and Dyer
method52. The lipids were recovered from the organic layer and redissolved in
chloroform/methanol (1:2) to a concentration equivalent to 5 µM of the input
protein. The extracted lipids (5–10 µl) were loaded onto a nanospray tip for
negative mode ESI−MS and multistage collision-induced dissociation tandem mass
(CID–MS) using linear ion trap mass spectrometer (LXQ, Thermo Scientiﬁc).
Collision energy was 20–35% of maximum and product ions were trapped with a q
value of 0.25. The negative ions were calibrated with external reference Hexakis
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(1H, 1H, 3H-tetraﬂuoropropoxy) phosphazine ([M+Cl]− at m/z 955.97 (Agilent
part # I8720241)).
Generation of T-cell lines. PBMC were obtained from leukoreduction collars
provided by the Brigham and Women’s Hospital Specimen Bank, as approved by
the Partners Healthcare IRB. Human PBMC and PBMC derived T-cells were
stained with tetramers at 2 μg ml−1 in PBS containing 1% BSA and 0.01% sodium
azide. Cells and tetramer were incubated for 10 min at room temperature, followed
by addition of 3 μl of anti-CD3 (clone SK7-Fitc from BD biosciences) per 50 μl
staining and another incubation for 10 min at room temperature and 20 min at
4 °C. PBMC were sorted for positive staining with anti-CD3 and the indicated
tetramers (Supplementary Fig. 1–5). Expansion of sorted cells was performed using
anti-CD3 at 30 ng ml−1 (clone OKT3), irradiated feeder cells, and IL-2. After
2 weeks, the sorting and expansion procedure was repeated once or multiple times.
When the resulting cell lines consisted mainly of tetramer+ T-cells, they were
screened for binding to a panel of antibodies against TCR Vβ and 2 μl of anti-CD4
(clone RPA-T4 from Biolegend) per 50 μl staining. Suitable combinations of
antibodies were used to isolate subsets of the original T-cell lines (Supplementary
Fig. 1-5). IFN-γ ELISPOT was performed using the 1D1K and GB-11-biotin
antibodies (Mabtech), according to the manufacturer’s instructions.
TCR sequencing and transduction. The TCR sequences were determined using
RNA isolated with an RNeasy kit (Qiagen), and cDNA synthesized with a Quan-
titect reverse transcription kit (Qiagen). V segment usage was determined by PCR
using primerset IPS000030 as described at www.imgt.org (Lefranc MP, 1989), as
well as by a multiplex approach53, followed by direct Sanger sequencing of the PCR
product. Full length TCRα and TCRβ chains were cloned into a self-cleaving 2A
peptide based (MSCV)-IRES-GFP (pMIG) vector54 and co-transfected into
HEK293T-cells in the presence of the retroviral packaging vectors pPAM-E and
pVSV-g. The supernatant from the transfected HEK293T-cells was harvested and
used to stably transduce TCR-deﬁcient Jurkat clone 76 cells55 to generate the
BC13A T-cell line. After 5 days, cells that had the highest expression of GFP and
CD3 were enriched by FACS sorting.
Protein expression and puriﬁcation. Recombinant BC8B TCR were cloned into
the pET30a vector and expressed, refolded and puriﬁed from E. coli inclusion
bodies24,56. Inclusion bodies were resuspended in 8M urea, 20 mM Tris–HCl (pH
8.0), 0.5 mM Na-EDTA, and 1 mM DTT. The TCR was refolded by ﬂash dilution
in a solution containing 5M urea, 100 mM Tris (pH 8.0), 2 mM Na-EDTA,
400 mM L-arginine-HCl, 0.5 mM oxidized glutathione, 5 mM reduced glutathione,
and EDTA-free anti-protease cocktail. The refolding solution was then dialyzed to
eliminate urea. The resulting protein solution was then puriﬁed by size exclusion
chromatography and HiTrap-Q anion exchange chromatography. Soluble CD1b
was expressed from either insect Trichoplusia ni High Five cell lines, or HEK 293 S
GnTI− (American Type Culture Collection), and puriﬁed by HisTrap Ni2+-afﬁnity
chromatography and size exclusion chromatography24,36. For SPR and crystal-
lography purposes, puriﬁed CD1b was loaded with a molar excess of target lipid in
the presence of tyloxapol (Sigma) over a 16 h incubation period at 20 °C, then
puriﬁed via anion exchange chromatography to homogeneity24,36.
Crystallization and structure determination. Crystals of the BC8B TCR were
grown via the hanging drop vapor diffusion method, using a protein-reservoir drop
ratio of 1:1, at a protein concentration of 5 mgml−1 in 10 mM Tris–HCl (pH 8.0),
with a crystallization condition of 20% (v/v) PEG 3350, 0.2 M Potassium sodium
tartrate tetrahydrate. Crystals of the CD1b-PC–BC8B TCR ternary complex were
grown at protein concentrations of 5 mgml−1, with a crystallization condition of
22% to 24% (v/v) PEG 3350, 0.01M Tris–HCl pH 7.0–7.4. Crystals of the CD1b-
PC complex were grown at protein concentrations between 5 and 8 mgml−1, with
a crystallization condition of 22–26% PEG 3350, 0.2 M Sodium Iodide. Crystals of
BC8B TCR, CD1b-PC–BC8B TCR, and CD1b-PC were soaked in a cryoprotectant
comprised of reservoir solution containing 10% (v/v) ethylene glycol, before being
ﬂash-frozen in liquid nitrogen. Data were collected at the Australian Synchrotron
at the MX2 beamline for the BC8B TCR and CD1b-PC–BC8B TCR crystals, and at
the MX1 beamline for the CD1b-PC crystals57. Data were processed using the
iMosﬂm software, and scaled using Aimless as part of the CCP4i program suite58.
Crystal structures were solved via Molecular replacement using Phaser as part of
the phenix program suite59, with the structures of CD1b-PG (PDB accession code:
5WL1), and GEM42 TCR (PDB accession code: 4G8F) used as models for solving
CD1b and TCR structures, respectively. Manual adjustments of the models were
conducted in the coot graphics program60, following maximum-likelihood
reﬁnement with Buster 2.1061. Electron density for ligands were well deﬁned in the
CD1b-PC–BC8B TCR structure. Electron density for regions of the PC molecule in
the CD1b-PC structure were less deﬁned, indicative of ﬂexibility. All molecular
representations were generated in PyMOL. BSA values were calculated using
areaimol, and contacts generated using the CONTACT program in the CCP4i
program suite58.
Surface plasmon resonance. SPR analysis on the BC8B TCR against CD1b-
phospholipids was conducted on the BIAcore 3000 instrument at 25 °C in 10 mM
Tris–HCl (pH 8.0), 150 mM NaCl, and 1% (w/v) bovine serum albumin24. Binding
of the recombinant, refolded TCR in solution to CD1b, loaded with exogenous
lipids and amine coupled to a CM5 chip, was analyzed. All experiments were
conducted as two or three independent experiments in duplicate. Data analysis and
visualization were generated using Graphpad Prism 7.0, using the 1:1 Langmuir
binding model.
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Structural data were deposited in the Protein Data Bank, with the following
accession codes: BC8B TCR (6CUH), CD1b-PC–BC8B (6CUG), and CD1b-PC
(6D64). All remaining data are available within the article and its supplementary
information ﬁles and from the corresponding authors on request. A reporting
summary for this article is available as a Supplementary Information ﬁle.
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